For years, advocacy programmes in ophthalmology have followed a familiar rhythm: identify key experts, give them a platform and trust that their influence will drive change. It’s a model that has served the industry well, but the way influence works is shifting, and fast.
AI is deciding whose voices are amplified. Sustainability has moved from the margins to the centre of clinical conversations. And influence itself is becoming more distributed, shaped by a wider, more diverse network of voices than ever before.
These shifts aren’t theoretical. They’re happening now. And whether you’re developing products or delivering care, they’re reshaping how innovation reaches the clinic.
AI isn’t just another tool, it’s deciding who gets heard
AI is no longer operating in the background. It’s quietly but powerfully determining who rises to the surface in clinical discussions.
- Search and sentiment tools amplify some voices over others.
- Influence networks are drifting away from familiar podium figures toward digital-native experts.
- Credibility is increasingly shaped by algorithms and data signals, not just institutional reputation.
The question isn’t if AI will reshape advocacy. It already is. The real challenge is whether we adapt quickly enough to stay ahead of it.
Sustainability is becoming a new lever of influence
For too long, sustainability has been treated as an operational or procurement issue. That’s no longer the case.
Across med-tech, environmental impact is becoming a clinical and reputational factor. Surgeons and hospitals are starting to scrutinise their choices more closely. Products with credible sustainability narratives aren’t just being marketed. They’re gaining traction through peer conversations and shared values.
Advocacy strategies that ignore this shift risk missing a powerful driver of change.
Diversity in KOL engagement isn’t optional anymore
The days of relying on the same few familiar names are behind us. Real influence now lives in many places – in emerging geographies, subspecialties, digital spaces and among rising voices who bring different lived experiences.
Diversity in advocacy isn’t about ticking a box. It’s about strength.
When more perspectives are heard, the narrative doesn’t just grow. It becomes more relevant, more credible and ultimately more powerful.
Leading in advocacy starts with better questions
At ArtiaCo., we spend a great deal of time exploring where advocacy is heading. But leadership isn’t about having all the answers. It starts with sharper questions:
- What new forms of influence are emerging and are we ready to engage with them?
- What signals are we missing because we’re still looking in the same places?
- What happens when advocacy stops reacting and starts leading?
The organisations that start asking these questions early will be the ones shaping the conversation later.
A new era for advocacy
Advocacy is no longer about a handful of familiar names on a stage. It’s about how influence is built, shared and sustained across a far more connected, fast-moving landscape.
AI, sustainability and diversity aren’t background signals. They’re the forces already reshaping how ideas spread and how innovation takes hold in ophthalmology.
The real question isn’t whether advocacy is changing. It’s whether we choose to adapt with it or get left behind.
Ready to rethink how influence works in ophthalmology?
ArtiaCo. helps companies and clinicians build advocacy that’s credible, diverse and future-ready. Book a discovery call to explore how smarter engagement can turn your expert relationships into lasting impact.
